Oruka Therapeutics, Inc. (ORKA) — Strategic Asset Allocation Index
Oruka Therapeutics, Inc. (ORKA) has a Strategic Asset Allocation Index of 22.6% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $252.02 Million) total $252.02 Million, measured against net assets of $1.11 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Oruka Therapeutics, Inc. to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Oruka Therapeutics, Inc. Strategic Asset Allocation Index (2024–2025)
This chart shows how Oruka Therapeutics, Inc.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the index stands at 22.6%, representing strategic assets of $252.02 Million against net assets of $1.11 Billion USD.
Annual Strategic Asset Allocation Index for Oruka Therapeutics, Inc. (2024–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Oruka Therapeutics, Inc. from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Oruka Therapeutics, Inc. (ORKA) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 30.2% | $142.54 Million | $- | $142.54 Million | $471.93 Million | ▲ +25.5 pp |
| 2024 | 4.7% | $18.07 Million | $- | $18.07 Million | $382.22 Million | — |